$NVO is a screaming buy - any day below 40.
The biggest problem is that you replaced a CEO with another CEO who are unable to communicate the narrative to the market. Sooner or later they will figure how to fix it.
$LLY is not suppose to be 10 x $NVO
Fierce Pharma has updated its oral obesity drug tracker for $NVO 's Oral Wegovy and $LLY 's Foundayo. It provides a great visual of how both launches are developing over time.
$NVO new UBT251 triple agonist beats $LLY Retatrutide at 24 weeks at 17.7% vs 17.5 less with even less side effects. The future of weight loss is going parabolic.
https://t.co/D48OV3twXN
$NVO
$NVO has now tested the 200 MMA twice in the last 6 months, while the monthly MACD is getting close to a golden cross.
And here’s the crazy part:
This combination hasn’t happened once since 1981.
Not once...
So yes, I understand why people are still worried about whether the exact bottom is in.
But at some point, you have to recognize when the setup in front of you is anything but ordinary.
JUST IN🚨 MAJOR DROP IN FOUNDAYO PRESCRIPTIONS 📉
$NVO oral Wegovy: 182K → 179K (-1.6%)
$LLY Foundayo: 64.2K → 57.9K (-9.8%)
#Flopdayo strikes again. Is the initial boost from free 30-day starter packs fading now that patients have to pay?
Meanwhile, oral Wegovy remains stable at a high level, well ahead of Foundayo.
Source: #IQVIA data cited by Jefferies / Citi
🚨 OVERHEARD IN $HIMS HOUSE
"HIMS price action since yesterday has been such obvious insider activity / manipulation. I guarantee news drops imminently re: fed peptide decision"
👀 👀 👀
Begroting niet rond. Bruggen storten in elkaar. Benzineprijs schiet door het dak. Maar we laten 150 kamerleden aantreden om te stemmen over een vlag.
Ik zit in Den Haag om problemen op te lossen. Niet om mee te doen aan dit soort sneue spelletjes.
Ik weiger er aan mee te doen.
Waar is de Tweede Kamer mee bezig? Het oplossen van de woningnood? Het terugsturen van immigranten? De belastingen verlagen? Nee, het hijsen van de “regenboogvlag”! @tomrusscher reageert op deze bizarre situatie.
Diepe schaamte voor mijn stad. Het feit dat we zelfs de wet niet meer kunnen handhaven en hamasfiguren die massamoord vieren niet gewoon kunnen arresteren en uitzetten.
Met spoed de hele kamer optrommelen om dit weekend de regenboogvlag te kunnen heisen. De staat van absurditeit in Nederland kan niet beter geïllustreerd worden. Terwijl we in oorlog raken met een kernmacht, boodschappen onbetaalbaar zijn en het land kraakt onder de asielinstroom.
Maar wat moet er volgens PRO nu geregeld? De regenboogvlag op dak van het parlement.
https://t.co/nUSYt1Rhg7
$HIMS WSJ reported that Trump admin is to weigh wether HIMS will be allowed to sell Peptides early through temporary approval.
This is really big news for HIMS, so big that the stock has dropped, it's classic shorters trying to exit and larger funds trying to buy in the cheap before the above news is circulated throughout the US media.
If the above wasnt major news, we would be 1% -/+. The fact that it has moved nearly 5%, shows insitutions who are short are in panic.
Buy and hold. Don't forget, 1.3 bil profit in 2030. Excluding peptides!!!! so if it gets approved peptides this year, who knows, maybe 1.7 bil profit in 2030? 2 bil profit in 2030? Market cap only 6 bil today! BUY BUY BUY BUY BUYBUBBUBUBUBUBUBUB lol